Final FDA rule on device, drug and biologic combos is available

01/23/2013 | MassDevice.com (Boston)

A final rule released this week by the FDA outlines current good manufacturing practice standards for products that combine drugs, medical devices and biologics. The rule aims to clarify the CGMP criteria for new and existing combination products that are sold together or are "single-entity" combinations.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC